Non-Small Cell Lung Cancer (NSCLC) Epidemiology Analysis and Forecast to 2032
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Non Small Cell Lung Cancer Epidemiology Analysis Report Overview
In the 8MM, there were 1,097,467 diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) in 2022. The diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) will register an AGR of more than 2% during 2022-2032. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, NSCLC can begin anywhere in the lungs when the healthy cells that make up the lining of the lungs change and grow out of control, forming a tumor. The disease is categorized into different histological types based on cell morphology. There are two main types: non-squamous cell carcinomas and squamous cell carcinomas. Non-squamous cell carcinomas include: – Adenocarcinoma – Large cell carcinoma – Other types such as undifferentiated or not otherwise specified carcinomas Squamous cell carcinomas are another type.
Non-Small Cell Lung Cancer (NSCLC) Market Outlook, 2022-2032 (Diagnosed Incident Cases)
Buy the Full Report for More Insights into the Multiple Myeloma Vaccine Market Forecast
The Non-Small Cell Lung Cancer (NSCLC) market research report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for Non-Small Cell Lung Cancer (NSCLC) in the 8 major markets namely the US, France, Germany, Italy, Spain, UK, Japan, and Urban China. The report also includes a 10-year epidemiology forecast for the diagnosed incident cases and diagnosed prevalent cases of multiple myeloma.
Market Size (2022) | 1,097,467 Cases |
AGR (2022-2032) | >2% |
Forecast Period | 2023 – 2032 |
Key Countries | · The US
· France · Germany · Spain · Italy · The UK · Japan · Urban China |
Key Sex Segments | · Men
· Women |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Non-Small Cell Lung Cancer (NSCLC) Market Segmentation by Country
The key countries across the 8MM are the US, France, Germany, Spain, Italy, the UK, Japan, and Urban China. In 2022, Urban China accounted for more than 53% of the diagnosed incident cases of MM in the 8MM. By 2032, Urban China will continue to have the highest number of diagnosed incident cases of MM in the 8MM, whereas Spain will have the fewest diagnosed incident cases. GlobalData epidemiologists forecast an increase in the diagnosed incident cases.
`Non-Small Cell Lung Cancer (NSCLC) Market Analysis by Country, 2032 (%)
Buy the Full Report for More Country Insights into the Multiple Myeloma Vaccine Market
Non-Small Cell Lung Cancer (NSCLC) Market Segmentation by Sex
Based on sex, the multiple myeloma vaccine market can be segmented into men and women. In 2022, the number of diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) was higher in men in the 8MM combined. Among the 8MM, Spain had the largest difference in the diagnosed incident cases of MM between men and women.
Non-Small Cell Lung Cancer (NSCLC) Market Analysis by Sex, 2022 (%)
Buy the Full Report for More Sex Insights into the Non-Small Cell Lung Cancer (NSCLC) Market
Segments Covered in the Report
Non-Small Cell Lung Cancer (NSCLC) Market Country Outlook (Diagnosed Incident Cases, 2022-2032)
- The US
- France
- Germany
- Spain
- Italy
- The UK
- Japan
- Urban China
Non-Small Cell Lung Cancer (NSCLC) Market Sex Outlook (Diagnosed Incident Cases, 2022-2032)
- Men
- Women
Scope
- This report provides an overview of the risk factors, comorbidities, and global and historical epidemiological trends for MM in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Urban China).
- The report includes a 10-year epidemiology forecast for the diagnosed incident and diagnosed prevalent cases of MM.
- The diagnosed incident cases of MM are segmented by age (18 years and older), by sex, by type (asymptomatic and symptomatic), by stage at diagnosis (R-ISS stage I, R-ISS stage II, and R-ISS stage III), by stem cell transplant (SCT) eligibility (eligible and ineligible), and by genetic and surface markers. The diagnosed prevalent cases of MM are segmented sex, by stage at diagnosis (R-ISS stage I, R-ISS stage II, and R-ISS stage III), and by genetic and surface markers [t(4;14)(p16;q32), t(14;16)(q32;q23), t(14;20) (q32;q12), t(11;14)(q13;q32), and deletion 17p].
- This epidemiology forecast for MM is supported by data obtained from peer-reviewed articles and population-based studies.
- The forecast methodology was kept consistent across the 8MM to allow for a meaningful comparison of the forecast diagnosed incident and diagnosed prevalent cases of MM across these markets.
Reasons to Buy
The Non-Small Cell Lung Cancer (NSCLC) epidemiology series will allow you to:
- Develop business strategies by understanding the trends shaping and driving the global MM market.
- Quantify patient populations in the global MM market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for MM therapeutics in each of the markets covered
Table of Contents
Table
Figures
Frequently asked questions
-
How many diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) were seen in the 8MM in 2022?
In 2022, there were 1,097,467 diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) in the 8MM.
-
What will be the growth rate of the Non-Small Cell Lung Cancer (NSCLC) market?
The diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) will register an AGR of more than 2% during 2022-2032.
-
Which was the leading sex segment in the Non-Small Cell Lung Cancer (NSCLC) market in 2022?
In 2022, the number of diagnosed prevalent cases of Non-Small Cell Lung Cancer (NSCLC) was higher in men in the 8MM combined.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.